NEWS CENTER

Connecting the World, Shaping the Future | Keyuan Pharmaceutical Debuts at CPHI China 2024, Taking Its Global Expansion to New Heights!

Publish Time:

2024-06-20

Jiang Hongsheng, Chairman and President of Keyuan Pharmaceutical, hosted an international VIP client symposium together with the company’s international marketing team. The event provided a platform for in-depth communication and exchange with partners from around the globe, aiming to strengthen relationships, foster mutual understanding, explore industry trends more thoroughly, stay attuned to the pulse of sector development, share research achievements and product insights, and jointly identify new opportunities for collaboration.

On June 19, the highly anticipated CPHI China 2024—World Pharmaceutical Ingredients Exhibition—officially kicked off in Shanghai, bringing together industry pioneers from around the globe to explore cutting-edge technologies and discuss potential collaborations and partnerships.

As a leading enterprise in China's niche segment of chemical APIs, Keyuan Pharmaceutical (stock code: 301281.SZ) has once again been invited to participate in the exhibition, showcasing its outstanding R&D capabilities and forward-looking international expansion strategy to the global audience—and taking yet another significant step forward in its globalization initiative.

Before the exhibition opened, Jiang Hongsheng, Chairman and President of Keyuan Pharmaceutical, together with the international marketing team, hosted an International VIP Client Dialogue Meeting. The event provided an in-depth platform for communication and exchange with partners from around the globe, aiming to strengthen relationships and mutual understanding, explore industry trends more thoroughly, stay attuned to the pulse of industry development, share research achievements and products, and jointly seek new opportunities for collaboration.

At the exhibition, Keyuan Pharmaceutical's booth became the center of attention, drawing crowds with its sleek and vibrant design in tech-inspired blue and medical-inspired white. Core products were neatly displayed, clearly highlighting the company’s key strengths, which attracted both new and existing customers to stop by, ask questions, and engage in lively conversations. The venue buzzed with activity, as attendees eagerly gathered around the eye-catching display.

As a company dedicated to the global pharmaceutical and healthcare industry, Keyuan Pharmaceutical has always regarded internationalization as one of its key growth strategies. All of our products have obtained national GMP certification, while our core offerings have successively passed official regulatory approvals from multiple countries, including the EU’s EDQM, the U.S. FDA, Japan’s PMDA, and South Korea’s MFDS—laying a solid foundation for the company’s ambitious international expansion plan.

For years, the company has steadily intensified its efforts to expand into overseas markets, actively seeking collaboration and exchanges with internationally renowned enterprises.

During this exhibition, Keyuan Pharmaceutical engaged in in-depth discussions with several internationally renowned companies and reached multiple strategic cooperation agreements. These partnerships will drive the company's further advancements in R&D, manufacturing, and sales, while strengthening Keyuan Pharmaceutical's global influence and competitiveness in the pharmaceutical market—and ultimately injecting fresh momentum into the company's internationalization strategy.

Connecting the world, shaping the future. Keway Pharmaceutical will move forward with even greater determination and an increasingly open mindset, upholding our mission to safeguard life and health through digital and intelligent medicine. We will continue to deepen our engagement in the pharmaceutical industry, actively expand into international markets, and contribute even more to the global advancement of healthcare and wellness!

Harnessing the Power of Talent, Building a Solid Foundation for Growth (Issue 1) | Keyuan Pharmaceutical Holds 2024 Management Trainee Onboarding Symposium, Strengthening Talent Pipeline Development and Paving the Way for Sustainable Growth!

Internationally recognized quality assurance | Keyuan Pharmaceutical achieves zero-defect status once again with U.S. FDA certification!